Groww Q2 Results: CAS Pain Hits Sequential Growth, But Brokerage Eyes Relief From SEBI Proposal
Groww is in focus in a quarterly results development.
· NDTV Profit
In its shareholder letter, management said the fall in Groww's equity derivatives revenue was in line with the broader industry trend.
The analysis
Against that, the stock is -0.7% on the day at ₹192.52, and has returned -5.5% over three months. It sits 13% below its 52-week high. The capital markets sector has moved -5.3% over the same period, so Groww is running 0.2 points behind its peers.
For Groww, the question is how much of this is already reflected in the price and how much re-rates the capital markets peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
- With SEBI involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- The company directly in focus is GROWW.
- Sector exposure: Capital Markets.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Groww Q2 results preview: MOFSL sees 41% revenue growth; margins, derivatives business in focus
Groww Q2 Results: Cons net profit surges 54% YoY to Rs 726 crore; revenue jumps 47%
Q2 2026 quarterly results today LIVE updates: BHEL, Groww, Canara Bank, CEAT, RIIL, MRPL, Tata Tech, HDB Fin, others
Stocks in news: Adani Enterprises, Hyundai Motor India, BHEL, BEL, Groww, Tata Elxsi and RailTel
IDBI Bank shares rally 13%, market value swells by Rs 11,460 crore amid muted market. What lies ahead?